Vitality Watch

⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.

Mentioned 9× · first seen 09-sep-2026 · last seen 16-nov-2026

Psychedelic Therapies

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-11-11 — Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration: [mechanism-plausible] A preclinical transcriptomic study reports LSD-induced gene-expression changes opposing signatures of brain aging and neurodegeneration, a molecular finding that does not establish reversal of brain aging, cognitive benefit, or human safety and supplies no media/community evidence of trend spread. [mechanism-plausible] (novelty: 3)
  • 2026-10-22 — Lysergic acid diethylamide extends lifespan in Caenorhabditis elegans.: [animal-model] A C. elegans study reported lifespan extension of up to 17.6% with chronic or transient early-adulthood nanomolar LSD exposure, implicating serotonergic GPCR signaling and caloric-restriction-like nutrient sensing; this is worm lifespan evidence, not evidence of human longevity benefits or safety, and the finding supplies no media/community evidence of trend spread. [animal-model] (novelty: 3)
  • 2026-08-17 — Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life: LONG-LIFE Phase I trial launched testing 1–3 doses of 25 mg psilocybin vs wait-list in adults 60–80 for aging biomarkers, cognition, and purpose in life — protocol/early-phase, no readout. [expert-opinion] (novelty: 4)
  • 2026-08-07 — Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin: Early-phase clinical trial protocol registered testing cognitive training plus intermittent oral psilocybin vs cognitive training alone for neuroplasticity in adults 65+ with MCI, early Alzheimer’s, or normal cognition — protocol-stage, no efficacy readout yet. [expert-opinion] (novelty: 3)

Open questions

Related

Contributing findings

rss expert media
Mushrooms for the Mind & Immune System | Paul Stamets
16-nov-2026 novelty 2 per-area 2 strengthens
rss preclinical mechanism-plausible
Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration
11-nov-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Lysergic acid diethylamide extends lifespan in Caenorhabditis elegans.
22-oct-2026 novelty 3 per-area 3 strengthens
rss expert media
How to Improve Motivation & Overcome Procrastination | Dr. Masud Husain
24-aug-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early expert-opinion
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
17-aug-2026 novelty 4 per-area 4 strengthens
rss expert media
#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn’t enough, and the future of psychedelic therapies | Linus Abrams, M.D.
17-aug-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early expert-opinion
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
07-aug-2026 novelty 3 per-area 3 strengthens
rss expert media
Essentials: Using Meditation to Focus, View Consciousness & Expand Your Mind | Dr. Sam Harris
23-jul-2026 novelty 2 per-area 1 mentions
rss expert media
The Mental Frame & Specific Daily Actions to Succeed | Andy Stumpf
15-jun-2026 novelty 2 per-area 2 mentions

build build 880 · 2bcef25 · 2026-11-18